China Money Network
Login
Join

Chinese Biotech Firm JW Therapeutics Closes $100M Series B Round

  • June 10, 2020 — 11:30 CST

This Data Is Locked!

This area is available only to Subscribers.

JW Therapeutics, a Shanghai-based clinical-stage biopharmaceutical company, has completed of a US$100 million series B round financing co-led by CPE and Mirae Asset. CR-CP Life... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: